Neurological Disorder Drug Discovery from Gene Expression with Tensor Decomposition

Author(s): Y-h. Taguchi*, Turki Turki

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 43 , 2019

Become EABM
Become Reviewer

Abstract:

Background: Identifying effective candidate drug compounds in patients with neurological disorders based on gene expression data is of great importance to the neurology field. By identifying effective candidate drugs to a given neurological disorder, neurologists would (1) reduce the time searching for effective treatments; and (2) gain additional useful information that leads to a better treatment outcome. Although there are many strategies to screen drug candidate in pre-clinical stage, it is not easy to check if candidate drug compounds can also be effective to human.

Objective: We tried to propose a strategy to screen genes whose expression is altered in model animal experiments to be compared with gene expressed differentially with drug treatment to human cell lines.

Methods: Recently proposed tensor decomposition (TD) based unsupervised feature extraction (FE) is applied to single cell (sc) RNA-seq experiments of Alzheimer’s disease model animal mouse brain.

Results: Four hundreds and one genes are screened as those differentially expressed during Aβ accumulation as age progresses. These genes are significantly overlapped with those expressed differentially with the known drug treatments for three independent data sets: LINCS, DrugMatrix, and GEO.

Conclusion: Our strategy, application of TD based unsupervised FE, is useful one to screen drug candidate compounds using scRNA-seq data set.

Keywords: Amyloid, alzheimer disease, gene expression, single-cell analysis, drug discovery, cell line.

[1]
Gribkoff VK, Kaczmarek LK. The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes. Neuropharmacology 2017; 120: 11-9.
[http://dx.doi.org/10.1016/j.neuropharm.2016.03.021] [PMID: 26979921]
[2]
Ransohoff RM. All (animal) models (of neurodegeneration) are wrong. Are they also useful? J Exp Med 2018; 215(12): 2955-8.
[http://dx.doi.org/10.1084/jem.20182042] [PMID: 30459159]
[3]
Amini GJS, White MK. General overview of neuronal cell culture. Methods Mol Biol 2013; 1078: 1-8.
[4]
Habib R, Noureen N, Nadeem N. Decoding common features of neurodegenerative disorders: from differentially expressed genes to pathways. Curr Genomics 2018; 19(4): 300-12.
[http://dx.doi.org/10.2174/1389202918666171005100549] [PMID: 29755292]
[5]
Avsec Ž, Kreuzhuber R, Israeli J, et al. The Kipoi repository accelerates community exchange and reuse of predictive models for genomics. Nat Biotechnol 2019; 37(6): 592-600.
[http://dx.doi.org/10.1038/s41587-019-0140-0] [PMID: 31138913]
[6]
Badrinarayanan V, Kendall A, Cipolla R. Segnet: a deep convolutional encoder-decoder architecture for image segmentation. IEEE Trans Pattern Anal Mach Intell 2017; 39(12): 2481-95.
[http://dx.doi.org/10.1109/TPAMI.2016.2644615] [PMID: 28060704]
[7]
Ghazi MM, Ekenel HK. A comprehensive analysis of deep learning based representation for face recognition. Proceedings of the IEEE conference on computer vision and pattern recognition workshops 34-41.
[http://dx.doi.org/10.1109/CVPRW.2016.20]
[8]
YH. Taguchi. Multiomics data analysis using tensor decomposition based unsupervised feature extraction inintelligent computing theories and application. Springer International Publishing 2019; pp. 565-74.
[9]
Taguchi YH. Unsupervised Feature Extraction Applied to Bioinformatics: A PCA Based and TD Based Approach Unsupervised and Semi-Supervised Learning. Springer International Publishing. 2019.
[10]
Taguchi YH, Ng. KaLok. Tensor decompositionabased unsupervised feature extraction for integrated analysis of TCGA data on micrRNA expression and promoter methylation of genes in ovarian cancer. In: 2018 IEEE 18th International Conference on Bioinformatics and Bioengineering (BIBE). 2018; pp. 195-200.
[11]
Taguchi YH. Identification of candidate drugs for heart failure using tensor decomposition-based unsupervised feature extraction applied to integrated analysis of gene expression between heart failure and DrugMatrix datasetsIntelligent Computing Theories and Application. Springer International Publishing 2017; pp. 517-28.
[http://dx.doi.org/10.1007/978-3-319-63312-1_45]
[12]
Taguchi YH. Identification of candidate drugs using tensor-decomposition-based unsupervised feature extraction in integrated analysis of gene expression between diseases and DrugMatrix datasets. Sci Rep 2017; 7(1): 13733.
[http://dx.doi.org/10.1038/s41598-017-13003-0] [PMID: 29062063]
[13]
Taguchi YH. One-class differential expression analysis using tensor decomposition-based unsupervised feature extraction applied to integrated analysis of multiple omics data from 26 lung adenocarcinoma cell lines. In: 2017 IEEE 17th International Conference on Bioinformatics and Bioengineering (BIBE). 2017; pp. 131-8.
[http://dx.doi.org/10.1109/BIBE.2017.00-66]
[14]
Taguchi YH. Tensor decomposition-based unsupervised feature extraction applied to matrix products for multi-view data processing. PLoS One 2017; 12(8) e0183933
[http://dx.doi.org/10.1371/journal.pone.0183933] [PMID: 28841719]
[15]
Taguchi YH. Tensor decomposition-based unsupervised feature extraction identifies candidate genes that induce post-traumatic stress disorder-mediated heart diseases. BMC Med Genomics 2017; 10(Suppl. 4): 67.
[http://dx.doi.org/10.1186/s12920-017-0302-1] [PMID: 29322921]
[16]
Taguchi YH. Tensor decomposition/principal component analysis based unsupervised feature extraction applied to brain gene expression and methylation profiles of social insects with multiple castes. BMC Bioinformatics 2018; 19(Suppl. 4): 99.
[http://dx.doi.org/10.1186/s12859-018-2068-7] [PMID: 29745827]
[17]
Taguchi YH. Tensor decomposition-based unsupervised feature extraction can identify the universal nature of sequence-nonspecific off-target regulation of mRNA mediated by microRNA transfection. Cells 2018; 7(6): 54.
[http://dx.doi.org/10.3390/cells7060054] [PMID: 29867052]
[18]
Taguchi YH. Drug candidate identification based on gene expression of treated cells using tensor decomposition-based unsupervised feature extraction for large-scale data. BMC Bioinformatics 2019; 19(13)(Suppl. 13): 388.
[19]
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57(1): 289-300.
[http://dx.doi.org/10.1111/j.2517-6161.1995.tb02031.x]
[20]
Maxim V, Kuleshov Matthew R, Jones Andrew D, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 2016; 44(W1): W90-7.
[21]
Kolda TG, Bader BW. Tensor decompositions and applications. SIAM Rev 2009; 51(3): 455-500.
[http://dx.doi.org/10.1137/07070111X]
[22]
Hore V, Vinuela A, Buil A, et al. Tensor decomposition for multiple-tissue gene expression experiments. Nat Genet 2016; 48(9): 1094-100.
[http://dx.doi.org/10.1038/ng.3624] [PMID: 27479908]
[23]
Acar E, Rasmussen MA, Savorani F, Næs T, Bro R. Understanding data fusion within the framework of coupled matrix and tensor factorizations. Multiway and Multiset Methods. Chemom Intell Lab Syst 2013; 129: 53-63.
[http://dx.doi.org/10.1016/j.chemolab.2013.06.006]
[24]
Fischer F, Matthisson M, Herrling P. List of drugs in development for neurodegenerative diseases. Neurodegener Dis 2004; 1(1): 50-70.
[http://dx.doi.org/10.1159/000077879] [PMID: 16908974]
[25]
Frigerio CS, Wolfs L, Fattorelli N, et al. The major risk factors for alzheimer’s disease: age, sex, and genes modulate the microglia response to a. Cell Rep 2019; 27(4): 1293-306. e6
[PMID: 31018141]
[26]
Leggio GM, Catania MV, Puzzo D, et al. The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice.a1-42. Pharmacol Res 2016; 106: 10-20.
[http://dx.doi.org/10.1016/j.phrs.2016.02.007] [PMID: 26875816]
[27]
Hein LK, Apaja PM, Hattersley K, et al. A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome. Biochim Biophys Acta Mol Cell Res 2017; 1864(10): 1554-65.
[http://dx.doi.org/10.1016/j.bbamcr.2017.06.011] [PMID: 28641977]
[28]
Van Den Heuvel C, Donkin JJ, Finnie JW, et al. Downregulation of amyloid precursor protein (APP) expression following post-traumatic cyclosporin-A administration. J Neurotrauma 2004; 21(11): 1562-72.
[http://dx.doi.org/10.1089/0897715042441783] [PMID: 15684649]
[29]
Eisele YS, Baumann M, Klebl B, Nordhammer C, Jucker M, Kilger E. Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-egrading enzyme neprilysin. Mol Biol Cell 2007; 18(9): 3591-600.
[http://dx.doi.org/10.1091/mbc.e07-01-0035] [PMID: 17626163]
[30]
Ferrer I, Blanco R. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 2000; 77(2): 270-6.
[http://dx.doi.org/10.1016/S0169-328X(00)00062-0] [PMID: 10837922]
[31]
Sakib CKMS, Jain G, Benito E, et al. Kmt2a and kmt2b mediate memory function by affecting distinct genomic regions. Cell Rep 2017; 20(3): 538-48.
[PMID: 28723559]
[32]
Huang KL, Marcora E, Pimenova AA, et al. International Genomics of Alzheimer’s Project; Alzheimer’s Disease Neuroimaging Initiative. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer’s disease. Nat Neurosci 2017; 20(8): 1052-61.
[http://dx.doi.org/10.1038/nn.4587] [PMID: 28628103]
[33]
Chia-Hsiung C, Weihui Z, Shengchun L, et al. Increased NF-K B signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int J Neuropsychopharmacol 2012; 15(1): 77-90.
[34]
Muller U, Herzfeld T, Nolte D. The TAF1/DYT3 multiple transcript system in X-linked dystonia-parkinsonism. Am J Hum Genet 2007; 81(2): 415-7.
[http://dx.doi.org/10.1086/519528] [PMID: 17668393]
[35]
Kelleher MB, Galutira D, Duggan TD, Nuovo GJ. Progressive multifocal leukoencephalopathy in a patient with Alzheimer’s disease. Diagn Mol Pathol 1994; 3(2): 105-13.
[http://dx.doi.org/10.1097/00019606-199406000-00007] [PMID: 8061888]
[36]
Nagaraj S, Laskowska-Kaszub K, Debski KJ, et al. Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects. Oncotarget 2017; 8(10): 16122-43.
[http://dx.doi.org/10.18632/oncotarget.15109] [PMID: 28179587]
[37]
Wang LL, Min L, Guo QD, et al. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer’s Disease. BioMed Res Int 2017; 2017 8030369
[http://dx.doi.org/10.1155/2017/8030369] [PMID: 29057267]
[38]
Kasandra B, Ivana M, Raghu M, et al. Profiles of extracellular mirna in cerebrospinal fluid and serum from patients with alzheimer’s and parkinson’s diseases correlate with disease status and features of pathology. PLoS One 2014; 9(5): 1-20.
[http://dx.doi.org/10.1371/journal.pone.0094839]
[39]
Zhang B, Chen CF, Wang AH, Lin QF. MiR-16 regulates cell death in Alzheimer’s disease by targeting amyloid precursor protein. Eur Rev Med Pharmacol Sci 2015; 19(21): 4020-7.
[PMID: 26592823]
[40]
Hebert SS, Wang WX, Zhu Q, Nelson PT. A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis 2013; 35(2): 335-48.
[http://dx.doi.org/10.3233/JAD-122350] [PMID: 23403535]
[41]
Liu QY, Chang MN, Lei JX, et al. Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease. Am J Neurodegener Dis 2014; 3(1): 33-44.
[http://dx.doi.org/10.1186/s12859-018-2395-8] [PMID: 30717646]
[42]
Rani A, O’Shea A, Ianov L, Cohen RA, Woods AJ, Foster TC. mirna in circulating microvesicles as biomarkers for age-related cognitive decline. Front Aging Neurosci 2017; 9: 323.
[http://dx.doi.org/10.3389/fnagi.2017.00323] [PMID: 29046635]
[43]
Xie B, Zhou H, Zhang R, et al. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment. J Alzheimers Dis 2015; 45(3): 721-31.
[http://dx.doi.org/10.3233/JAD-142847] [PMID: 25589731]
[44]
Litzenburger UM, Buenrostro JD, Wu B, et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol 2017; 18(1): 15.
[http://dx.doi.org/10.1186/s13059-016-1133-7] [PMID: 28118844]
[45]
Yuan D, Tao Y, Chen G, Shi T. Systematic expression analysis of ligand-receptor pairs reveals important cell-to-cell interactions inside glioma. Cell Commun Signal 2019; 17(1): 48.
[http://dx.doi.org/10.1186/s12964-019-0363-1] [PMID: 31118022]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 43
Year: 2019
Page: [4589 - 4599]
Pages: 11
DOI: 10.2174/1381612825666191210160906

Article Metrics

PDF: 22
HTML: 8
EPUB: 1